Jaguar Health, Inc.
JAGX
$2.58
$0.010.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.21M | 3.51M | 3.11M | 2.72M | 2.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.21M | 3.51M | 3.11M | 2.72M | 2.35M |
| Cost of Revenue | 515.00K | 557.00K | 541.00K | 427.00K | 430.00K |
| Gross Profit | 1.70M | 2.95M | 2.57M | 2.29M | 1.92M |
| SG&A Expenses | 7.39M | 6.58M | 5.79M | 5.84M | 5.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.64M | 11.67M | 10.37M | 9.92M | 10.57M |
| Operating Income | -9.42M | -8.16M | -7.26M | -7.20M | -8.22M |
| Income Before Tax | -10.60M | -10.23M | -10.02M | -9.63M | -9.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.60M | -10.23M | -10.02M | -9.63M | -9.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 132.00K | 314.00K | 167.00K | 136.00K | 142.00K |
| Net Income | -10.46M | -9.92M | -9.85M | -9.49M | -9.23M |
| EBIT | -9.42M | -8.16M | -7.26M | -7.20M | -8.22M |
| EBITDA | -8.94M | -7.68M | -6.79M | -6.75M | -7.71M |
| EPS Basic | -16.70 | -20.83 | -26.29 | -101.00 | -87.12 |
| Normalized Basic EPS | -10.36 | -12.77 | -16.26 | -62.58 | -61.30 |
| EPS Diluted | -16.70 | -20.83 | -26.29 | -101.00 | -87.12 |
| Normalized Diluted EPS | -10.36 | -12.77 | -16.26 | -62.58 | -61.30 |
| Average Basic Shares Outstanding | 626.60K | 476.30K | 374.80K | 94.00K | 105.90K |
| Average Diluted Shares Outstanding | 626.60K | 476.30K | 374.80K | 94.00K | 105.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |